AstraZeneca Pharma India Limited (BOM:506820)
India · Delayed Price · Currency is INR 8,514.50
-6.10 (-0.07%)
At close: Jun 18, 2026
AstraZeneca Pharma India Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 17, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 212,863 | 193,986 | 215,159 | 133,010 | 81,183 | 63,886 | |
Market Cap Growth | 7.52% | -9.84% | 61.76% | 63.84% | 27.07% | -15.11% |
Enterprise Value | 209,483 | 190,335 | 210,362 | 127,861 | 76,552 | 60,484 |
Last Close Price | 8514.50 | 7759.45 | 8577.01 | 5284.39 | 3211.62 | 2520.50 |
PE Ratio | 113.51 | 103.45 | 185.90 | 82.35 | 81.76 | 103.71 |
PS Ratio | 9.35 | 8.53 | 12.54 | 10.27 | 8.09 | 7.93 |
PB Ratio | 24.39 | 22.23 | 27.93 | 18.68 | 13.79 | 12.49 |
P/TBV Ratio | 24.39 | 22.23 | 27.95 | 18.74 | 13.79 | 12.49 |
P/FCF Ratio | - | - | 338.25 | 777.38 | 163.12 | 70.07 |
P/OCF Ratio | - | - | 329.19 | 477.25 | 139.27 | 63.38 |
EV/Sales Ratio | 9.21 | 8.36 | 12.26 | 9.87 | 7.63 | 7.51 |
EV/EBITDA Ratio | 79.95 | 72.64 | 84.67 | 69.81 | 47.45 | 73.16 |
EV/EBIT Ratio | 89.73 | 81.53 | 97.93 | 74.58 | 51.43 | 87.20 |
EV/FCF Ratio | - | - | 330.71 | 747.29 | 153.81 | 66.33 |
Debt / Equity Ratio | 0.13 | 0.13 | 0.05 | 0.01 | 0.01 | 0.02 |
Debt / EBITDA Ratio | 0.42 | 0.42 | 0.14 | 0.02 | 0.04 | 0.10 |
Debt / FCF Ratio | - | - | 0.56 | 0.27 | 0.14 | 0.10 |
Net Debt / Equity Ratio | -0.39 | -0.39 | -0.65 | -0.70 | -0.84 | -0.86 |
Net Debt / EBITDA Ratio | -1.29 | -1.29 | -2.01 | -2.73 | -3.06 | -5.32 |
Net Debt / FCF Ratio | 20.24 | 20.24 | -7.87 | -29.28 | -9.91 | -4.82 |
Asset Turnover | 1.30 | 1.30 | 1.32 | 1.26 | 1.09 | 0.99 |
Inventory Turnover | 1.75 | 1.75 | 2.50 | 2.87 | 2.22 | 2.11 |
Quick Ratio | 0.68 | 0.68 | 1.05 | 1.89 | 1.61 | 1.64 |
Current Ratio | 1.77 | 1.77 | 1.91 | 2.61 | 2.18 | 2.12 |
Return on Equity (ROE) | 22.82% | 22.82% | 15.62% | 24.84% | 18.05% | 12.73% |
Return on Assets (ROA) | 8.32% | 8.32% | 10.34% | 10.39% | 10.11% | 5.32% |
Return on Invested Capital (ROIC) | 35.84% | 43.14% | 66.13% | 82.29% | 131.87% | 54.86% |
Return on Capital Employed (ROCE) | 23.20% | 23.20% | 26.40% | 23.80% | 24.80% | 13.20% |
Earnings Yield | 0.88% | 0.97% | 0.54% | 1.21% | 1.22% | 0.96% |
FCF Yield | -0.08% | -0.09% | 0.30% | 0.13% | 0.61% | 1.43% |
Dividend Yield | 0.42% | 0.46% | 0.37% | 0.45% | 0.50% | 0.40% |
Payout Ratio | 42.66% | 42.66% | 51.84% | 24.77% | 20.14% | 8.12% |
Buyback Yield / Dilution | 0.00% | 0.00% | - | - | - | - |
Total Shareholder Return | 0.43% | 0.47% | 0.37% | 0.45% | 0.50% | 0.40% |